Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2833 (LINC02833)
- Target
- LINC02833
- Molecular classification
- Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other (does not fit protein-based target families such as receptor, transporter, etc.)
01
Overview
Long intergenic non-protein coding RNA 2833 (LINC02833) is a member of the class of long intergenic non-coding RNAs (lincRNAs). It is transcribed as an RNA molecule but does not encode a protein[1][5][3]. LincRNAs are characterized by their length (>200 nucleotides) and their location between annotated protein-coding genes. They are a subclass of long non-coding RNAs (lncRNAs) and are thought to function primarily in the regulation of gene expression at epigenetic, transcriptional, and post-transcriptional levels[3]. Specific biological functions, disease associations, and interaction data for LINC02833 have not yet been elucidated in the scientific literature or databases[1][5].
- Other names
- LINC02833Long intergenic non-protein coding RNA 2833
02
Biological functions
Functions of LINC02833 specifically are not described in detail; most lincRNAs are implicated in diverse gene regulation, including:RNA stabilizationTranscription regulationChromatin remodelingEnhancer-associated activityOther potential regulatory rolesFor most individual human lincRNAs, detailed, experimentally validated biological functions are unknown
03
Disease associations
Not explicitly established for LINC02833.Many lincRNAs, in general, have been linked to cancer and other human diseases where they may act by regulating oncogenes, tumor suppressors, or cellular pathwaysNo specific disease associations are reported for LINC02833 as of the current literature and gene databases
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2833 (LINC02833).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2833 (LINC02833).